Feb 28, 2018 9:00am EST Pieris Pharmaceuticals to Host Full-Year 2017 Investor Call and Corporate Update on March 9, 2018
Feb 19, 2018 8:30am EST Pieris Pharmaceuticals to Present at the RBC Capital Markets 2018 Global Healthcare Conference
Feb 16, 2018 5:36pm EST Pieris Pharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Option to Purchase Additional Shares
Feb 09, 2018 6:45am EST Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration
Dec 07, 2017 8:30am EST Pieris Pharmaceuticals Announces Ethics and Regulatory Clearance to Begin Clinical Testing of Inhaled Respiratory Program, PRS-060/AZD1402
Nov 21, 2017 8:30am EST Pieris Pharmaceuticals Appoints James Geraghty as Chairman of the Board of Directors
